[ Price : $8.95]
Federal Register Notice: FDA determines the regulatory review period for Bayer Animal Healths Veraflox for the purpose of patent e...[ Price : $8.95]
Justice Department official says the days of a money-only penalty in corporate criminal settlements is long over and company offic...[ Price : $8.95]
Public Citizen says its analysis of FDA records shows many reports of INRatio injuries and malfunctions in patients before a clini...[ Price : $8.95]
FDA accepts for priority review a Pfizer supplemental NDA for its breast cancer medication, Ibrance (palbociclib) for an expanded ...[ Price : $8.95]
An online study sets the rate of leiomyosarcoma among women undergoing morcellation at 1 of 429 per 1,000 hysterectomies, riskier ...[ Price : $8.95]
Federal Register Notice: FDA seeks comments on a proposed collection of information on interviews of pharmaceutical manufacturers ...[ Price : $8.95]
Federal Register Notice: FDA determines the regulatory review period for Bristol-Myers Squibbs Eliquis for the purpose of patent e...[ Price : $8.95]
An FDA advisory committee votes 11 to 3 to recommend approval of a Teva Pharmaceutical Industries BLA for Cinqair (reslizumab) for...